Clinicopathological features | Cases No (n, %) | miR-126 expression status | P | |
---|---|---|---|---|
Low (n, %) | High (n, %) | |||
Age | ||||
<70 | 70 (54.69) | 39 (55.71) | 31 (44.29) | NS |
≥70 | 58 (45.31) | 29 (50.00) | 29 (50.00) | |
Preoperative PSA | ||||
<4 ng/mL | 3 (2.34) | 0 (0) | 3 (100.00) | 0.003 |
4-10 ng/mL | 35 (27.34) | 7 (20.00) | 28 (80.00) | |
>10 ng/mL | 90 (70.31) | 61 (67.77) | 29 (32.23) | |
Gleason score | ||||
4-6 | 62 (48.44) | 31 (50.00) | 31 (50.00) | NS |
7 | 30 (23.44) | 19 (63.33) | 11 (36.67) | |
8-10 | 36 (28.13) | 18 (50.00) | 18 (50.00) | |
Pathological stage | ||||
T1 | 72 (56.25) | 22 (30.56) | 50 (69.44) | 0.001 |
T2/T3 | 56 (43.75) | 46 (82.14) | 10 (17.86) | |
Lymph node metastasis | ||||
Negative | 106 (82.81) | 47 (44.34) | 59 (55.66) | 0.006 |
Positive | 22 (17.19) | 21 (95.45) | 1 (4.55) | |
Angiolymphatic invasion | ||||
Negative | 110 (85.94) | 50 (45.45) | 60 (54.55) | 0.001 |
Positive | 18 (14.06) | 18 (100.00) | 0 (0) | |
Surgical margin status | ||||
Negative | 108 (84.38) | 56 (51.85) | 52 (48.15) | NS |
Positive | 20 (15.62) | 12 (60.00) | 8 (40.00) |